William Blair Comments on Avantor’s Q1 Earnings (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) – William Blair decreased their Q1 2025 earnings per share estimates for shares of Avantor in a report released on Monday, February 10th. William Blair analyst M. Larew now expects that the company will post earnings per share of $0.22 for the quarter, down from their previous estimate of $0.24. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. William Blair also issued estimates for Avantor’s Q2 2025 earnings at $0.26 EPS, Q4 2025 earnings at $0.30 EPS, FY2025 earnings at $1.07 EPS, Q1 2026 earnings at $0.27 EPS, Q2 2026 earnings at $0.30 EPS, Q3 2026 earnings at $0.31 EPS, Q4 2026 earnings at $0.35 EPS and FY2026 earnings at $1.23 EPS.

Several other brokerages also recently issued reports on AVTR. Barclays decreased their target price on Avantor from $26.00 to $23.00 and set an “overweight” rating on the stock in a research note on Monday. Robert W. Baird decreased their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. Morgan Stanley decreased their target price on Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday. Royal Bank of Canada decreased their target price on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research note on Monday. Finally, Raymond James reissued an “outperform” rating and set a $24.00 target price (down previously from $26.00) on shares of Avantor in a research note on Monday. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $26.15.

Avantor Stock Up 0.4 %

AVTR stock opened at $18.12 on Wednesday. Avantor has a twelve month low of $17.90 and a twelve month high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The stock has a market cap of $12.33 billion, a P/E ratio of 39.38, a PEG ratio of 3.87 and a beta of 1.28. The business’s 50-day moving average price is $21.57 and its 200-day moving average price is $23.35.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.24% and a net margin of 4.54%. During the same quarter in the previous year, the company posted $0.22 EPS.

Institutional Trading of Avantor

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Dodge & Cox increased its stake in Avantor by 44.9% in the fourth quarter. Dodge & Cox now owns 99,145,770 shares of the company’s stock worth $2,089,001,000 after purchasing an additional 30,727,673 shares during the period. Vanguard Group Inc. grew its position in shares of Avantor by 1.9% during the 4th quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company’s stock worth $1,347,843,000 after buying an additional 1,211,418 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its position in shares of Avantor by 41.4% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company’s stock worth $643,227,000 after buying an additional 8,936,879 shares in the last quarter. State Street Corp grew its position in shares of Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock worth $578,666,000 after buying an additional 8,206,695 shares in the last quarter. Finally, Canada Pension Plan Investment Board grew its position in shares of Avantor by 0.5% during the 4th quarter. Canada Pension Plan Investment Board now owns 21,037,089 shares of the company’s stock worth $443,251,000 after buying an additional 112,644 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.